← Back to headlines
Genmab Reports 19% Revenue Growth to $3.7B in 2025
Genmab reported a 19% increase in revenue, reaching $3.7 billion in 2025, primarily fueled by sales of its proprietary medicines.
20 Feb, 09:10 — 20 Feb, 09:10
ℹOnly 1 source covers this story
